Those who have been following the saga of the leukemia wonder drug imatinib mesylate or Glivec (spelled Gleevec in North America to standardize pronunciation) may recall that it was said to be the first medicine for which a global price was set. At the time of its 2001 FDA approval, the worldwide price was US$2400/month, [...]
Archive for the ‘Access to Medicines’ Category
News Roundup
Posted in Access to Medicines, Advocacy, Conflicts of Interest, Consumer Protection, Economics of Health Care, Ethics, Global Health, Health Care Marketing, Health Care Reform, Health Insurance, Healthcare Inequalities, Prescription drugs, Promotions, Tobacco control on 9 January 2012 | Leave a Comment »
As the new year starts, some ome items of note from near and far: The breast implant scandal strips away the glossy euphemisms of cosmetic surgery S. Korea approves Asia’s first anti-leukemia drug Nicotine Gum and Skin Patch Face New Doubt No Benefits for Sick Job Seekers: After battling leukemia, man is denied unemployment benefits Opinion: [...]
And the good news is…
Posted in Access to Medicines, Advocacy, Assistance, Children's Health, Consumer Protection, Economics of Health Care, Health Insurance, Pharmacists, Prescription drugs, State of Washington on 7 November 2011 | Leave a Comment »
Now more so that ever, learning of positive developments and new efforts of those working to make a difference, helps me to keep going . I share here with you some news of significance at the local, state, and national levels. In Washington State: State lifts three-visit ER limit for poor patients Workers’ wellness saving [...]
Headline Scan
Posted in Access to Medicines, Advocacy, Assistance, Children's Health, Economics of Health Care, Environmental Health, Ethics, Global Health, Health Care Marketing, Health Disparities, Health Insurance, Health Literacy, Healthcare Inequalities, Language Access, Recession, State of Washington, Workers' rights on 18 May 2011 | Leave a Comment »
Can We Afford Personalized Medicine? Special treatment for ‘high profile’ patients; exasperation for the rest of us Health Insurers Making Record Profits as Many Postpone Care People Who Donate Organs For Transplants Can Have Difficulty Getting Insurance Foundations, Conflicts Of Interest And Drugmakers Mission Crash: The Intolerable Policy Incoherence in US AIDS Policy, Global and [...]
